Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-040540
Filing Date
2025-02-28
Accepted
2025-02-28 06:14:42
Documents
6
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 6-K d932055d6k.htm 6-K 9141
2 EX-99.1 d932055dex991.htm EX-99.1 37674
3 EX-99.2 d932055dex992.htm EX-99.2 21024
4 GRAPHIC g932055g0228090927224.jpg GRAPHIC 2601
5 GRAPHIC g932055g0228091225317.jpg GRAPHIC 2601
6 GRAPHIC g932055g02s86.jpg GRAPHIC 2226
  Complete submission text file 0001193125-25-040540.txt   79733
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 25682373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)